查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2005120

支台齒植入市場：依材料、產品類型、最終用戶、連接方式及通路分類－2026-2032年全球市場預測

Abutment Implants Market by Material, Product Type, End User, Connection Type, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年支台齒植入市場價值為 5.5118 億美元，預計到 2026 年將成長至 5.9218 億美元，複合年成長率為 6.88%，到 2032 年將達到 8.7824 億美元。

主要市場統計數據
基準年 2025 5.5118億美元
預計年份：2026年 5.9218億美元
預測年份 2032 8.7824億美元
複合年成長率 (%) 6.88%

對現代支台齒植入市場進行簡要概述，重點關注材料和製造技術的創新，以及不斷變化的臨床和採購重點。

支台齒和植入領域正處於先進生物材料、精密製造和不斷發展的臨床實踐的交匯點。近年來，臨床醫生和醫療設備製造商之間的合作日益緊密，旨在改善產品的美觀、功能性和長期組織反應。同時，設計和製造方面的創新正在縮短前置作業時間，並實現更高程度的客製化。因此，從手術團隊到採購負責人，相關人員都在重新評估產品選擇標準，優先考慮產品的耐用性、軟組織整合性和能夠縮短病患反應時間的高效工作流程。

材料的飛躍、數位化製造的採用以及採購管道的演變，正在重新定義產品策略和臨床部署路徑。

支台齒植入領域正經歷一場變革，其驅動力來自材料創新、數位化製造以及不斷變化的臨床偏好。臨床醫生越來越傾向於選擇能夠最大限度地減少軟組織併發症並帶來可預測美學效果的解決方案，這促使製造商在改進鈦合金系統的同時，加大對氧化鋯材料的研發投入。這種材料研發的融合反映了整個產業從標準化組件轉向根據患者的解剖結構和美學需求量身定做的解決方案的趨勢。

本研究檢驗了美國近期的關稅措施如何重塑整個支台齒植入生態系統的採購選擇、供應鏈彈性策略和採購實踐。

美國近期關稅政策的變化進一步增加了基支台齒植入採購和供應鏈計算的複雜性。進口關稅及相關貿易措施不僅影響接收成本，還會影響採購決策、庫存策略和供應商選擇標準。進口商和經銷商正在透過重新評估供應商所在地、探索近岸外包方案以及協商更清晰地分配貿易風險的合約條款來應對這些變化。

詳細的細分分析揭示了材料選擇、客製化生產方法、最終用戶需求、連接形狀和多樣化的通路如何影響臨床應用和商業策略。

細分市場層面的趨勢清楚地展現了整個基植入支台齒市場的需求和創新集中方向。材料差異正在影響產品定位。鈦因其悠久的臨床應用歷史和優異的機械強度而備受青睞，而氧化鋯則在注重美觀的領域日益普及。氧化鋯的演進包括單片氧化鋯（適用於特定的高強度應用）和多層氧化鋯（在前牙修復中具有更優的光學性能）。這些材料進步正在影響臨床醫生的建議和修復通訊協定。

區域比較分析顯示，美洲、歐洲、中東、非洲和亞太地區在實施模式、監管多樣性和採購方法的複雜程度方面存在差異。

區域趨勢對策略規劃至關重要，因為不同地區的採用模式、法律規範和採購慣例差異顯著。在美洲，完善的臨床網路、高比例的私人牙科診所和先進的報銷機制，促進了成熟的鈦合金系統和新興的二氧化鋯替代方案的快速普及。該地區採購流程的日益精細化，使得整合服務交付和增值技術支援成為主流，從而影響了供應商的選擇，而不僅限於價格比較。

競爭情報概述揭示了成熟企業和敏捷的新參與企業如何利用臨床關係、製造能力和數位夥伴關係來打入市場。

支台齒植入領域的競爭格局呈現出多元化的態勢，既有成熟的植入系統供應商，也有專業組件製造商，還有新興的數位化先鋒參與企業。成熟的製造商憑藉著深厚的臨床關係、豐富的法規遵循經驗和廣泛的分銷網路，在醫療採購管道中保持著穩固的地位。這些成熟企業通常優先考慮產品改進、供應可靠性和臨床教育項目，以維持外科醫生和修復科醫生的支持。

為協助高階主管協調產品、製造、分銷和臨床醫生參與策略，以加速產品推廣和商業性成功，提供切實可行的優先建議。

產業領導者應優先考慮一系列切實可行的舉措，將技術能力轉化為商業性優勢。首先，他們應圍繞臨床差異化的價值提案整合產品系列組合，使其與當地需求和終端使用者的工作流程相契合。這意味著在材料和連接方式的選擇上，應顯著改善美學和生物學效果，同時清晰地向外科醫生和修復團隊傳達這些優勢。

對混合方法研究途徑進行透明的解釋，該方法整合了對臨床醫生的訪談、技術文獻和監管審查，以產生具有實際意義的見解。

本研究結合了對臨床醫生、採購負責人和生產專家的訪談，以及對同行評審的臨床文獻、監管申報文件和產品規格說明的全面審查。這種方法強調三角驗證，將臨床發現與生產能力和分銷實際情況進行交叉檢驗，以確保結論不僅反映臨床需求，也反映營運可行性。

簡潔的整合突顯了材料、製造、臨床檢驗和商業策略的融合，以此作為實現永續應用和改善病患療效的途徑。

支台齒和植入領域正處於轉折點，材料科學、數位化製造和商業策略的融合正在重塑臨床實踐。鈦的可靠性已得到充分驗證，而氧化鋯因其美觀性和軟組織修復效果而日益受到關注，這就要求製造商協調這些材料的選擇、基台的形狀以及修復流程，以確保治療效果的一致性。雖然數位化製造方法和客製化解決方案正在降低個人化治療的門檻，但這些進步也需要對品管系統和臨床醫生培訓進行相應的投入。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：支台齒植入市場：依材料分類

  • 鈦
  • 氧化鋯
    • 整體式氧化鋯
    • 多層氧化鋯

第9章：支台齒植入市場：依產品類型分類

  • 風俗
    • 3D列印
    • CAD/CAM
  • 庫存

第10章：基台植入市場：依最終用戶支台齒

  • 牙醫診所
  • 醫院
  • 專科診所

第11章 依連接類型支台齒植入市場

  • 球形連接器
  • 外六邊形
  • 內六角形

第12章：支台齒植入市場：依通路分類

  • 離線
  • 線上

第13章：基台植入市場：依地區支台齒

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：支台齒植入市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：基台植入市場：依國家支台齒

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國支台齒植入市場

第17章：中國支台齒植入市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • ACE Surgical Supply Co
  • ADIN Dental Implant Systems Ltd
  • Bicon LLC
  • BioHorizons Inc
  • Camlog Biotechnologies AG
  • Cortex Dental Implants Industries Ltd
  • Dentium Co Ltd
  • Dentsply Sirona Inc
  • DIO Implant Co Ltd
  • Envista Holdings Corporation
  • Glidewell Laboratories
  • Henry Schein Inc
  • Ivoclar Vivadent AG
  • Keystone Dental Inc
  • MegaGen Implant Co Ltd
  • MIS Implants Technologies Ltd
  • Neoss Ltd
  • Nobel Biocare Services AG
  • Osstem Implant Co Ltd
  • Southern Implants
  • Straumann Holding AG
  • Sweden & Martina SpA
  • Thommen Medical AG
  • Zest Anchors LLC
  • ZimVie Inc
Product Code: MRR-B16853776B87

The Abutment Implants Market was valued at USD 551.18 million in 2025 and is projected to grow to USD 592.18 million in 2026, with a CAGR of 6.88%, reaching USD 878.24 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 551.18 million
Estimated Year [2026] USD 592.18 million
Forecast Year [2032] USD 878.24 million
CAGR (%) 6.88%

A concise orientation to the contemporary abutment implant landscape highlighting materials, manufacturing innovations, and shifting clinical and procurement priorities

The abutment implant sector sits at the intersection of advanced biomaterials, precision manufacturing, and evolving clinical practice. Recent years have seen clinicians and device manufacturers collaborate more closely to improve esthetics, functionality, and long-term tissue response, while innovations in design and production are reducing lead times and enabling greater customization. As a result, stakeholders from surgical teams to procurement officers are revisiting product selection criteria to prioritize durability, soft-tissue integration, and streamlined workflows that reduce chair time.

Transitioning from research-driven experimentation to clinically validated solutions has sharpened competitive dynamics. Developers are balancing proven titanium systems with the growing clinical appetite for zirconia alternatives, which promise superior aesthetics for anterior restorations and improved soft tissue outcomes in select patient cohorts. At the same time, advances in digital dentistry-driven by CAD/CAM and additive manufacturing-are reconfiguring supply chains and expanding the range of viable custom solutions. These technological shifts are complemented by evolving reimbursement frameworks and procurement behaviors that favor demonstrable clinical benefits and cost-efficient supply models.

Taken together, the industry is moving toward integrated offerings that combine material science, manufacturing agility, and evidence-based clinical protocols. Decision-makers require concise, actionable intelligence to navigate trade-offs among material choices, connection geometries, and distribution strategies, ensuring that product investments align with both clinician expectations and patient outcomes.

How material breakthroughs, digital manufacturing adoption, and evolving procurement channels are collectively redefining product strategies and clinical adoption pathways

The abutment implant arena is undergoing transformative shifts driven by material innovation, digital manufacturing, and changing clinical preferences. Clinicians are increasingly favoring solutions that deliver predictable esthetic outcomes while minimizing soft-tissue complications, prompting manufacturers to invest in zirconia development alongside improvements in titanium systems. This convergence of material pathways reflects a broader industry move from one-size-fits-all components toward tailored solutions that match patient anatomy and esthetic demands.

Simultaneously, digital workflows are maturing. CAD/CAM systems and additive manufacturing have moved from experimental to operational use in many specialty clinics and dental laboratories, enabling faster turnaround for custom abutments and reducing dependency on centralized production. The ability to produce patient-specific geometries improves prosthetic fit and clinician satisfaction, while also placing pressure on traditional stock product providers to differentiate on speed, cost, or integrated service offerings.

Procurement channels are also evolving. Healthcare buyers and clinic operators are adopting procurement strategies that weigh clinical evidence, total cost of ownership, and supply resilience. Distribution models extend beyond traditional distributors to include direct tender arrangements and e-commerce platforms that streamline ordering and inventory management. These combined shifts require suppliers to be agile across manufacturing, regulatory compliance, and commercial models to maintain clinical relevance and secure long-term adoption.

Examining how recent United States tariff measures are reshaping sourcing choices, supply chain resilience strategies, and procurement behavior across the abutment implant ecosystem

Recent tariff developments in the United States have injected additional complexity into the procurement and supply-chain calculus for abutment implants. Import duties and related trade measures affect not only landed cost but also sourcing decisions, inventory strategies, and supplier selection criteria. Importers and distributors are responding by reassessing supplier footprints, considering nearshoring options, and negotiating contract terms that more explicitly allocate trade-related risk.

Clinicians and institutional buyers are feeling indirect effects through pricing pressures and altered product availability. In some instances, higher landed costs have accelerated conversations about local manufacturing and domestic capacity building, with stakeholders assessing the feasibility of shifting production to regions with favorable trade relationships or closer proximity to end-users. At the same time, manufacturers outside of tariff jurisdictions are leveraging their relative cost advantage to pursue expanded distribution agreements and to strengthen relationships with national distributors.

Operationally, supply chain teams are refining inventory policies to buffer against volatility, increasing visibility across tiered suppliers, and identifying alternative components or materials that maintain clinical performance while reducing exposure to tariff-related cost swings. Regulatory compliance and quality control remain paramount during any sourcing transition, and successful organizations are those that balance cost management with the rigorous clinical and safety standards required for implantable dental components.

In-depth segmentation analysis revealing how material choices, custom production methods, end-user demands, connection geometries, and diverse distribution routes shape clinical adoption and commercial strategy

Segment-level dynamics offer a nuanced view of where demand and innovation are concentrating across the abutment implant space. Material distinctions drive product positioning: titanium continues to be prized for its long-standing clinical performance and mechanical strength, while zirconia is gaining traction where esthetic considerations are paramount. Zirconia's evolution includes both monolithic zirconia options, favored for certain high-strength applications, and multi-layer zirconia variants that offer improved optical properties for anterior restorations; these material pathways are shaping clinician recommendations and restorative protocols.

Product type segmentation differentiates off-the-shelf stock abutments from increasingly popular custom solutions. Custom abutments are being delivered via CAD/CAM workflows and additive manufacturing techniques such as 3D printing, enabling individualized emergence profiles and enhanced soft-tissue management. This capability is particularly valued in complex cases where prosthetic contours and esthetics are critical, whereas stock abutments retain relevance for standardized cases that prioritize cost efficiency and rapid availability.

End users vary in clinical needs and procurement sophistication. Dental clinics frequently pursue solutions that streamline chairside workflows and improve aesthetic outcomes, hospitals emphasize compatibility with broader surgical protocols and inventory management, and specialty clinics prioritize advanced restorative options and bespoke components. Connection type matters clinically and operationally; ball connector systems, external hex, and internal hex interfaces each offer distinct surgical handling characteristics and prosthetic considerations that influence clinician preference and inventory strategy. Finally, distribution channels influence access and purchasing behavior. Direct tender arrangements offer large institutional buyers predictable supply terms, distributors provide breadth of product offerings and local service, and online channels are simplifying ordering for smaller practices and enabling faster replenishment. These segmentation lenses collectively inform product development, commercial targeting, and supply chain design.

Comparative regional intelligence showing how adoption patterns, regulatory diversity, and procurement sophistication differ across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics are central to strategic planning as adoption patterns, regulatory frameworks, and procurement practices vary significantly across geographies. In the Americas, strong clinical networks, high levels of private dental practice penetration, and advanced reimbursement environments support rapid uptake of both established titanium systems and emerging zirconia alternatives. Procurement sophistication in this region often favors integrated service offerings and value-added technical support, influencing vendor selection beyond simple price comparisons.

Across Europe, Middle East & Africa, the regulatory landscape and heterogeneous healthcare systems lead to differentiated adoption curves. Some markets show early enthusiasm for aesthetic-driven zirconia solutions and digitally enabled services, while others rely on traditional titanium-based systems due to entrenched clinical protocols and supply relationships. Distributors play a pivotal role in bridging manufacturer capabilities with diverse clinical settings, and cross-border trade considerations influence sourcing strategies and distribution footprints.

In Asia-Pacific, rapid investment in dental infrastructure, growing middle-class demand for elective dental procedures, and an expanding network of specialty clinics are driving innovation adoption. Manufacturers looking to expand in this region must navigate varied regulatory requirements, local manufacturing expectations, and evolving clinician preferences that increasingly value both aesthetic outcomes and digitally integrated workflows. Each region presents distinct opportunities and constraints, and companies that tailor their product, regulatory, and commercial approaches to regional realities are better positioned to capture clinical adoption and build durable partnerships.

Competitive intelligence overview identifying how incumbents and agile entrants leverage clinical relationships, manufacturing capabilities, and digital partnerships to win adoption

Competitive dynamics in the abutment implant segment reflect a mix of established implant system providers, specialty component manufacturers, and emerging digital-first entrants. Established manufacturers leverage deep clinical relationships, extensive regulatory experience, and broad distribution networks to maintain presence in institutional procurement channels. These incumbents often prioritize incremental product enhancements, supply reliability, and clinical education programs to sustain preference among surgeons and restorative dentists.

Concurrently, smaller and more agile companies are carving niches by focusing on material innovation, customized manufacturing workflows, or digital integration that shortens delivery cycles. These entrants frequently collaborate with dental laboratories and specialty clinics to validate performance and to build clinical case libraries that support adoption. Partnerships between component manufacturers and digital-platform providers are also becoming more common, creating bundled offerings that simplify the transition to CAD/CAM or additive workflows for clinicians who lack in-house digital capabilities.

Across the competitive landscape, firms that combine demonstrable clinical outcomes with flexible manufacturing and responsive distribution tend to win adoption. Strategic investments in regulatory pathways, clinician training, and after-sales technical support are differentiators. The most successful organizations align product development with the practical realities of clinical workflows and procurement processes, ensuring that innovations translate into tangible benefits at the point of care.

Practical, prioritized recommendations for executives to align product, manufacturing, distribution, and clinician engagement strategies to accelerate adoption and commercial success

Industry leaders should prioritize a set of actionable initiatives to convert technical capability into commercial advantage. First, align product portfolios around clinically differentiated value propositions that match regional demands and end-user workflows. This means advancing material and connection decisions that demonstrably improve esthetic and biological outcomes while communicating those benefits clearly to surgeons and restorative teams.

Second, invest in digital and manufacturing flexibility. Expanding CAD/CAM compatibility and selective use of additive manufacturing can reduce lead times for custom abutments and enhance clinician satisfaction. Equally important is the development of robust quality and regulatory processes that permit rapid iteration without compromising safety or compliance.

Third, refine distribution strategies to balance reach with service. A hybrid approach that combines direct tender relationships for large institutional buyers, selective distributor partnerships for market coverage, and targeted online channels for smaller practices can optimize accessibility and control. Finally, strengthen clinician engagement through targeted education, case support, and evidence generation that underscores clinical benefits. By integrating these initiatives, companies can reduce friction in adoption pathways and create sustainable differentiation.

Transparent explanation of the mixed-methods research approach that integrates clinician interviews, technical literature, and regulatory review to produce operationally relevant insights

This research synthesizes primary interviews with clinicians, procurement officers, and manufacturing experts, combined with a careful review of peer-reviewed clinical literature, regulatory filings, and documented product specifications. The approach emphasizes triangulation: clinical insights are cross-validated against manufacturing capabilities and distribution realities to ensure conclusions reflect operational feasibility as well as clinical desirability.

Primary qualitative research involved structured conversations with restorative dentists, oral surgeons, dental lab managers, and supply-chain leaders to understand drivers of product selection, tolerance for new materials, and the practicalities of integrating custom solutions into existing workflows. Secondary sources focused on material science developments, published comparative studies on abutment outcomes, and regulatory guidance that informs product registration and clinical use. Wherever possible, technical claims were corroborated by device documentation and clinical case series to provide a balanced assessment.

Analytical methods prioritize actionable synthesis over broad numerical forecasting. The study highlights practical implications, trade-offs, and decision levers for stakeholders considering product development, market entry, or portfolio optimization, ensuring recommendations are grounded in both clinical practice and commercial realities.

A concise synthesis emphasizing the convergence of materials, manufacturing, clinical validation, and commercial strategy as the pathway to durable adoption and improved patient outcomes

The abutment implant sector stands at an inflection point where material science, digital manufacturing, and commercial strategy converge to reshape clinical practice. Titanium's legacy of reliable performance coexists with growing interest in zirconia for aesthetic and soft-tissue outcomes, and manufacturers must reconcile these material choices with connection geometries and prosthetic workflows to deliver consistent results. Digital production methods and customized solutions are reducing barriers to tailored care, yet these advances require parallel investments in quality systems and clinician education.

Procurement and distribution dynamics are also evolving, with tariff considerations and regional regulatory differences prompting a re-evaluation of sourcing and inventory strategies. Organizations that proactively address supply-chain resilience, while maintaining rigorous clinical validation, will be better positioned to navigate volatility. Ultimately, success favors companies that couple technical excellence with pragmatic commercialization: clear evidence of clinical benefit, responsive manufacturing capabilities, and channel strategies aligned to end-user needs.

Leaders who focus on integrated offerings-materials, manufacturing, clinical support, and distribution-can convert innovation into market adoption and deliver superior patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Abutment Implants Market, by Material

  • 8.1. Titanium
  • 8.2. Zirconia
    • 8.2.1. Monolithic Zirconia
    • 8.2.2. Multi-Layer Zirconia

9. Abutment Implants Market, by Product Type

  • 9.1. Custom
    • 9.1.1. 3D Printed
    • 9.1.2. CAD/CAM
  • 9.2. Stock

10. Abutment Implants Market, by End User

  • 10.1. Dental Clinics
  • 10.2. Hospitals
  • 10.3. Specialty Clinics

11. Abutment Implants Market, by Connection Type

  • 11.1. Ball Connector
  • 11.2. External Hex
  • 11.3. Internal Hex

12. Abutment Implants Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. Abutment Implants Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Abutment Implants Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Abutment Implants Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Abutment Implants Market

17. China Abutment Implants Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. ACE Surgical Supply Co
  • 18.6. ADIN Dental Implant Systems Ltd
  • 18.7. Bicon LLC
  • 18.8. BioHorizons Inc
  • 18.9. Camlog Biotechnologies AG
  • 18.10. Cortex Dental Implants Industries Ltd
  • 18.11. Dentium Co Ltd
  • 18.12. Dentsply Sirona Inc
  • 18.13. DIO Implant Co Ltd
  • 18.14. Envista Holdings Corporation
  • 18.15. Glidewell Laboratories
  • 18.16. Henry Schein Inc
  • 18.17. Ivoclar Vivadent AG
  • 18.18. Keystone Dental Inc
  • 18.19. MegaGen Implant Co Ltd
  • 18.20. MIS Implants Technologies Ltd
  • 18.21. Neoss Ltd
  • 18.22. Nobel Biocare Services AG
  • 18.23. Osstem Implant Co Ltd
  • 18.24. Southern Implants
  • 18.25. Straumann Holding AG
  • 18.26. Sweden & Martina SpA
  • 18.27. Thommen Medical AG
  • 18.28. Zest Anchors LLC
  • 18.29. ZimVie Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ABUTMENT IMPLANTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ABUTMENT IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ABUTMENT IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ABUTMENT IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY MONOLITHIC ZIRCONIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY MONOLITHIC ZIRCONIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY MONOLITHIC ZIRCONIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY MULTI-LAYER ZIRCONIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY MULTI-LAYER ZIRCONIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY MULTI-LAYER ZIRCONIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY 3D PRINTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY 3D PRINTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY 3D PRINTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY CAD/CAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY CAD/CAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY CAD/CAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY STOCK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY STOCK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY STOCK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY DENTAL CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY DENTAL CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY BALL CONNECTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY BALL CONNECTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY BALL CONNECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY EXTERNAL HEX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY EXTERNAL HEX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY EXTERNAL HEX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY INTERNAL HEX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY INTERNAL HEX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY INTERNAL HEX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS ABUTMENT IMPLANTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. GCC ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 133. GCC ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 134. GCC ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. GCC ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 136. GCC ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. GCC ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. GCC ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. G7 ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. G7 ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. G7 ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 158. G7 ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. G7 ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 160. G7 ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. G7 ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. G7 ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. NATO ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. NATO ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 165. NATO ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 166. NATO ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. NATO ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 168. NATO ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. NATO ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. NATO ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL ABUTMENT IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES ABUTMENT IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA ABUTMENT IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA ABUTMENT IMPLANTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA ABUTMENT IMPLANTS MARKET SIZE, BY ZIRCONIA, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA ABUTMENT IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA ABUTMENT IMPLANTS MARKET SIZE, BY CUSTOM, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA ABUTMENT IMPLANTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA ABUTMENT IMPLANTS MARKET SIZE, BY CONNECTION TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA ABUTMENT IMPLANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)